Literature DB >> 28247337

Widening the Heterogeneity of Leigh Syndrome: Clinical, Biochemical, and Neuroradiologic Features in a Patient Harboring a NDUFA10 Mutation.

Francesca Minoia1, Marta Bertamino2, Paolo Picco3, Mariasavina Severino4, Andrea Rossi4, Chiara Fiorillo5, Carlo Minetti5, Claudia Nesti6, Filippo Maria Santorelli6, Maja Di Rocco2.   

Abstract

Leigh syndrome (LS) is an early-onset progressive neurodegenerative disorder, characterized by a wide clinical and genetic heterogeneity, and is the most frequent disorder of mitochondrial energy production in children. Beside its great variability in clinical, biochemical, and genetic features, LS is pathologically uniformly characterized by multifocal bilateral and symmetric spongiform degeneration of the basal ganglia, brainstem, thalamus, cerebellum, spinal cord, and optic nerves. Isolated complex I deficiency is the most common defect identified in Leigh syndrome. In 2011, the first child with a mutation of NDUFA10 gene, coding for an accessory subunits of complex I, was described. Here, we present an additional description of a child with Leigh syndrome harboring a homozygous mutation in NDUFA10, providing insights in clinical, biochemical, and neuroradiologic features for future earlier recognition.

Entities:  

Keywords:  Complex I deficiency; Leigh syndrome; Mitochondrial disorders; NDUFA10 gene; Neuroradiologic features

Year:  2017        PMID: 28247337      PMCID: PMC5740043          DOI: 10.1007/8904_2017_9

Source DB:  PubMed          Journal:  JIMD Rep        ISSN: 2192-8304


  27 in total

Review 1.  Leigh syndrome: One disorder, more than 75 monogenic causes.

Authors:  Nicole J Lake; Alison G Compton; Shamima Rahman; David R Thorburn
Journal:  Ann Neurol       Date:  2015-12-15       Impact factor: 10.422

Review 2.  The origin of the supernumerary subunits and assembly factors of complex I: A treasure trove of pathway evolution.

Authors:  Dei M Elurbe; Martijn A Huynen
Journal:  Biochim Biophys Acta       Date:  2016-04-15

Review 3.  Leigh syndrome: Resolving the clinical and genetic heterogeneity paves the way for treatment options.

Authors:  Mike Gerards; Suzanne C E H Sallevelt; Hubert J M Smeets
Journal:  Mol Genet Metab       Date:  2015-12-19       Impact factor: 4.797

4.  Leigh syndrome with nephropathy and CoQ10 deficiency due to decaprenyl diphosphate synthase subunit 2 (PDSS2) mutations.

Authors:  Luis Carlos López; Markus Schuelke; Catarina M Quinzii; Tomotake Kanki; Richard J T Rodenburg; Ali Naini; Salvatore Dimauro; Michio Hirano
Journal:  Am J Hum Genet       Date:  2006-10-27       Impact factor: 11.025

5.  NDUFA10 mutations cause complex I deficiency in a patient with Leigh disease.

Authors:  Saskia J G Hoefs; Francjan J van Spronsen; Ellen W H Lenssen; Leo G Nijtmans; Richard J Rodenburg; Jan A M Smeitink; Lambert P van den Heuvel
Journal:  Eur J Hum Genet       Date:  2010-12-08       Impact factor: 4.246

6.  Whole-exome sequencing identifies novel ECHS1 mutations in Leigh syndrome.

Authors:  Martine Tetreault; Somayyeh Fahiminiya; Hana Antonicka; Grant A Mitchell; Michael T Geraghty; Matthew Lines; Kym M Boycott; Eric A Shoubridge; John J Mitchell; Jacques L Michaud; Jacek Majewski
Journal:  Hum Genet       Date:  2015-06-23       Impact factor: 4.132

7.  Leigh Syndrome and the Mitochondrial m.13513G>A Mutation: Expanding the Clinical Spectrum.

Authors:  Laura Monlleo-Neila; Mireia Del Toro; Belen Bornstein; Elena Garcia-Arumi; Axel Sarrias; Manuel Roig-Quilis; Francina Munell
Journal:  J Child Neurol       Date:  2012-10-03       Impact factor: 1.987

8.  Mutant NDUFV2 subunit of mitochondrial complex I causes early onset hypertrophic cardiomyopathy and encephalopathy.

Authors:  Paule Bénit; Réjane Beugnot; Dominique Chretien; Irina Giurgea; Pascale De Lonlay-Debeney; Jean-Paul Issartel; Marisol Corral-Debrinski; Stefan Kerscher; Pierre Rustin; Agnès Rötig; Arnold Munnich
Journal:  Hum Mutat       Date:  2003-06       Impact factor: 4.878

9.  Leigh syndrome: clinical features and biochemical and DNA abnormalities.

Authors:  S Rahman; R B Blok; H H Dahl; D M Danks; D M Kirby; C W Chow; J Christodoulou; D R Thorburn
Journal:  Ann Neurol       Date:  1996-03       Impact factor: 10.422

Review 10.  The genetics of Leigh syndrome and its implications for clinical practice and risk management.

Authors:  Ilene S Ruhoy; Russell P Saneto
Journal:  Appl Clin Genet       Date:  2014-11-13
View more
  6 in total

Review 1.  NDUFS6 related Leigh syndrome: a case report and review of the literature.

Authors:  Cécile Rouzier; Annabelle Chaussenot; Konstantina Fragaki; Valérie Serre; Samira Ait-El-Mkadem; Christian Richelme; Véronique Paquis-Flucklinger; Sylvie Bannwarth
Journal:  J Hum Genet       Date:  2019-04-04       Impact factor: 3.172

2.  Most mitochondrial dGTP is tightly bound to respiratory complex I through the NDUFA10 subunit.

Authors:  Yolanda Cámara; Ramon Martí; David Molina-Granada; Emiliano González-Vioque; Marris G Dibley; Raquel Cabrera-Pérez; Antoni Vallbona-Garcia; Javier Torres-Torronteras; Leonid A Sazanov; Michael T Ryan
Journal:  Commun Biol       Date:  2022-06-23

Review 3.  Analysis of Human Mutations in the Supernumerary Subunits of Complex I.

Authors:  Quynh-Chi L Dang; Duong H Phan; Abigail N Johnson; Mukund Pasapuleti; Hind A Alkhaldi; Fang Zhang; Steven B Vik
Journal:  Life (Basel)       Date:  2020-11-20

Review 4.  Involvement of the Spinal Cord in Mitochondrial Disorders.

Authors:  Josef Finsterer; Sinda Zarrouk-Mahjoub
Journal:  J Neurosci Rural Pract       Date:  2018 Apr-Jun

5.  Subversion of Host Cell Mitochondria by RSV to Favor Virus Production is Dependent on Inhibition of Mitochondrial Complex I and ROS Generation.

Authors:  MengJie Hu; Marie A Bogoyevitch; David A Jans
Journal:  Cells       Date:  2019-11-11       Impact factor: 6.600

6.  Bi-allelic pathogenic variants in NDUFC2 cause early-onset Leigh syndrome and stalled biogenesis of complex I.

Authors:  Ilka Wittig; Daniele Ghezzi; Robert W Taylor; Ahmad Alahmad; Alessia Nasca; Juliana Heidler; Kyle Thompson; Monika Oláhová; Andrea Legati; Eleonora Lamantea; Jana Meisterknecht; Manuela Spagnolo; Langping He; Seham Alameer; Fahad Hakami; Abeer Almehdar; Anna Ardissone; Charlotte L Alston; Robert McFarland
Journal:  EMBO Mol Med       Date:  2020-09-24       Impact factor: 14.260

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.